Press releaseGlobe Newswire
CG Oncology
CGON · NASDAQ
$61.93+$1.97 (+3.29%)TodayMarket closed ·
Prev close $59.96
Latest news
- Press releasePRNewswire
Kuehn Law Encourages Investors of CG Oncology, Inc. to Contact Law Firm
- News
10 Health Care Stocks Whale Activity In Today’s Session
- Press releasePRNewswire
Kuehn Law Encourages Investors of CG Oncology, Inc. to Contact Law Firm
- Press releaseGlobe Newswire
CG Oncology Reports Second Quarter 2026 Financial Results and Provides Business Updates
- Press releaseGlobe Newswire
CG Oncology Announces Publication of Pivotal Phase 3 BOND-003 Cohort C Study Results in The Lancet Oncology
- Press releaseGlobe Newswire
The New War on Cancer: Four Public Companies Helping Lead a Medical Revolution
- Press releaseGlobe Newswire
CG Oncology Reports Positive First Results from CORE‑008 Cohort CX Phase 2 Trial Evaluating Intravesical Combination Therapy in High-Risk BCG-Exposed and BCG-Unresponsive Patients
- NewsAvi Kapoor
CG Oncology Analysts Boost Their Forecasts Following Q1 Earnings
- Press releaseGlobe Newswire
CG Oncology Reports First Quarter 2026 Financial Results and Provides Business Updates
- News
What Analysts Are Saying About CG Oncology Stock
- News
CG Oncology Q4 Earnings Report: What Investors Need to Know
- Press releaseGlobe Newswire
CG Oncology Reports 2025 Year End Financial Results and Provides Business Updates
- News
Expert Outlook: CG Oncology Through The Eyes Of 7 Analysts
- News
What Analysts Are Saying About CG Oncology Stock
- Press releaseGlobe Newswire
Oncolytics Biotech® Appoints John McAdory as EVP of Strategy and Operations and Yujun Wu to Lead Biostatistics
- Press releasePRNewswire
Fast-Tracking the $537B Cancer Cure: How Accelerated Approvals Reshaping Oncology in 2026
- NewsAvi Kapoor
Crude Oil Rises Sharply; US Consumer Sentiment Edges Higher In January
- Press releaseGlobe Newswire
CG Oncology Provides Updated Timeline for PIVOT-006 Phase 3 Topline Data in Intermediate-Risk NMIBC
- Press releasePRNewswire
Breakthrough Therapy Designations Surge as $50B Cancer Drug Partnerships Reshape Market
- News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- News
Beyond The Numbers: 7 Analysts Discuss CG Oncology Stock
- Press releasePRNewswire
Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs
- Press releasePRNewswire
Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs
- Press releasePRNewswire
Cancer Rates Are Surging in Young Adults -- Here's Where the Smart Money Is Going
- NewsAvi Kapoor
Crude Oil Down 2%; Roper Technologies Increases 2025 Outlook
- NewsVandana Singh
CG Oncology's Bladder Cancer Drug Impresses Investors - Here's Why
- NewsAvi Kapoor
Dow Jumps Over 150 Points; Domino's Pizza Posts Upbeat Earnings
- Press releaseGlobe Newswire
CG Oncology Reports 2024 Year End Financial Results and Provides Business Updates
- NewsVandana Singh
CG Oncology Touts Encouraging Data From Late-Stage Study Of Bladder Cancer Candidate
- NewsAvi Kapoor
This Sempra Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.